Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | monoglyceride lipase | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | esterase, putative | monoglyceride lipase | 303 aa | 254 aa | 19.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | dna polymerase eta | 0.0044 | 0.4103 | 1 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0084 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0044 | 0.4103 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0025 | 0.1286 | 0.0889 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0084 | 1 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0084 | 1 | 1 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0025 | 0.1286 | 0.0889 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0084 | 1 | 1 |
Plasmodium vivax | PST-A protein | 0.0084 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0084 | 1 | 1 |
Plasmodium falciparum | lysophospholipase, putative | 0.0084 | 1 | 1 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.0031 | 0.2187 | 1 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0044 | 0.4103 | 0.3834 |
Mycobacterium leprae | POSSIBLE LYSOPHOSPHOLIPASE | 0.0084 | 1 | 0.5 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0044 | 0.4103 | 1 |
Trichomonas vaginalis | valacyclovir hydrolase, putative | 0.0084 | 1 | 1 |
Trypanosoma cruzi | monoglyceride lipase, putative | 0.0084 | 1 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0084 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0025 | 0.1286 | 0.3135 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.1286 | 0.0889 |
Plasmodium falciparum | esterase, putative | 0.0084 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.1286 | 0.2319 |
Mycobacterium ulcerans | lysophospholipase | 0.0084 | 1 | 1 |
Leishmania major | monoglyceride lipase, putative | 0.0084 | 1 | 1 |
Giardia lamblia | DINP protein human, muc B family | 0.0019 | 0.0436 | 0.5 |
Plasmodium falciparum | lysophospholipase, putative | 0.0084 | 1 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.1286 | 0.0889 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0019 | 0.0436 | 0.1062 |
Leishmania major | DNA polymerase eta, putative | 0.0044 | 0.4103 | 0.3834 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0084 | 1 | 1 |
Schistosoma mansoni | DNA polymerase eta | 0.0044 | 0.4103 | 1 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0031 | 0.2187 | 0.1831 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0044 | 0.4103 | 0.3834 |
Mycobacterium ulcerans | hypothetical protein | 0.0084 | 1 | 1 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0084 | 1 | 1 |
Echinococcus granulosus | dna polymerase eta | 0.0044 | 0.4103 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0084 | 1 | 1 |
Plasmodium falciparum | lysophospholipase, putative | 0.0084 | 1 | 1 |
Leishmania major | DNA polymerase eta, putative | 0.0031 | 0.2187 | 0.1831 |
Mycobacterium tuberculosis | Possible lysophospholipase | 0.0084 | 1 | 1 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0084 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 3.61 | Inhibition of Homo sapiens (human) recombinant fatty acid amide hydrolase assessed as inhibition of [3H]-AEA hydrolysis after 10 min by liquid scintillation counting | ChEMBL. | No reference |
IC50 (binding) | = 5.02 | Inhibition of Homo sapiens (human) recombinant monoacylglycerol lipase assessed as inhibition of [3H]-2-oleolylglycerol hydrolysis after 10 min by liquid scintillation counting | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.